HAV attachment to cells is calcium-dependent and does not involve RGD sequences or the immunodominant neutralization site, informing future vaccine and antiviral design.
No takes yet. Share an insight, caveat, or question.
HAV receptor insights may guide antiviral strategies; leaves open human translation from cell-line data.
Stapleton et al. (1991) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: